Cargando…

Natriuresis-guided diuretic therapy in acute heart failure: a pragmatic randomized trial

Measurement of natriuresis has been suggested as a reliable, easily obtainable biomarker for assessment of the response to diuretic treatment in patients with acute heart failure (AHF). Here, to assess whether natriuresis-guided diuretic therapy in patients with AHF improves natriuresis and clinical...

Descripción completa

Detalles Bibliográficos
Autores principales:	ter Maaten, Jozine M., Beldhuis, Iris E., van der Meer, Peter, Krikken, Jan A., Postmus, Douwe, Coster, Jenifer E., Nieuwland, Wybe, van Veldhuisen, Dirk J., Voors, Adriaan A., Damman, Kevin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group US 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10579092/ https://www.ncbi.nlm.nih.gov/pubmed/37640861 http://dx.doi.org/10.1038/s41591-023-02532-z

Ejemplares similares

Natriuresis‐guided therapy in acute heart failure: rationale and design of the Pragmatic Urinary Sodium‐based treatment algoritHm in Acute Heart Failure (PUSH‐AHF) trial
por: ter Maaten, Jozine M., et al.
Publicado: (2022)

Clinical importance of urinary sodium excretion in acute heart failure
por: Damman, Kevin, et al.
Publicado: (2020)

Urinary sodium evaluation: the missing target for diuretic treatment optimization in acute heart failure patients? Reply
por: Damman, Kevin, et al.
Publicado: (2020)

A combined clinical and biomarker approach to predict diuretic response in acute heart failure
por: ter Maaten, Jozine M., et al.
Publicado: (2015)

Higher doses of loop diuretics limit uptitration of angiotensin-converting enzyme inhibitors in patients with heart failure and reduced ejection fraction
por: ter Maaten, Jozine M., et al.
Publicado: (2020)

Early treatment with tolvaptan improves diuretic response in acute heart failure with renal dysfunction
por: Matsue, Yuya, et al.
Publicado: (2017)

Effects of empagliflozin on renal sodium and glucose handling in patients with acute heart failure
por: Boorsma, Eva M., et al.
Publicado: (2020)

Dipeptidyl peptidase 3, a marker of the antagonist pathway of the renin–angiotensin–aldosterone system in patients with heart failure
por: Boorsma, Eva M., et al.
Publicado: (2021)

Fibroblast growth factor 23 mediates the association between iron deficiency and mortality in worsening heart failure
por: van der Wal, Haye H., et al.
Publicado: (2020)

Worsening renal function in acute heart failure in the context of diuretic response
por: Emmens, Johanna E., et al.
Publicado: (2021)

Role of Early Assesment of Diuresis and Natriuresis in Detecting In-Hospital Diuretic Resistance in Acute Heart Failure
por: García-Magallón, Belén, et al.
Publicado: (2022)

Clinical implications of low estimated protein intake in patients with heart failure
por: Streng, Koen W., et al.
Publicado: (2022)

Proenkephalin and the risk of new‐onset heart failure: data from prevention of renal and vascular end‐stage disease
por: Emmens, Johanna E., et al.
Publicado: (2021)

The value of spot urinary creatinine as a marker of muscle wasting in patients with new‐onset or worsening heart failure
por: Pandhi, Paloma, et al.
Publicado: (2021)

Current and novel renal biomarkers in heart failure
por: Damman, Kevin, et al.
Publicado: (2011)

Outcomes Associated With a Strategy of Adjuvant Metolazone or High‐Dose Loop Diuretics in Acute Decompensated Heart Failure: A Propensity Analysis
por: Brisco‐Bacik, Meredith A., et al.
Publicado: (2018)

Current Understanding of Pressure Natriuresis
por: Baek, Eun Ji, et al.
Publicado: (2021)

Pain score, desire for pain treatment and effect on pain satisfaction in the emergency department: a prospective, observational study
por: van Zanden, Judith E., et al.
Publicado: (2018)

Albuminuria as a marker of systemic congestion in patients with heart failure
por: Boorsma, Eva M, et al.
Publicado: (2022)

Disconnect between the effects of serelaxin on renal function and outcome in acute heart failure
por: Beldhuis, I. E., et al.
Publicado: (2023)

Adrenomedullin in heart failure: pathophysiology and therapeutic application
por: Voors, Adriaan A., et al.
Publicado: (2018)

Orthostatic blood pressure recovery patterns in suspected syncope in the emergency department
por: van Wijnen, Veera K, et al.
Publicado: (2018)

Additive value of dobutamine stress echocardiography in patients with an anomalous origin of a coronary artery
por: Lameijer, Heleen, et al.
Publicado: (2015)

A patient with recurrent syncope—it does matter how slow and long you go
por: Roseboom, Eva, et al.
Publicado: (2023)

A patient with recurrent syncope—it does matter how slow and long you go
por: Roseboom, Eva, et al.
Publicado: (2023)

Role for ovarian hormones in purinoceptor-dependent natriuresis
por: Gohar, Eman Y., et al.
Publicado: (2020)

Pressure-Natriuresis Response Is Diminished in Old Age
por: Kim, Yang Gyun, et al.
Publicado: (2022)

The influence of atrial fibrillation on the levels of NT-proBNP versus GDF-15 in patients with heart failure
por: Santema, Bernadet T., et al.
Publicado: (2019)

Correction to: The influence of atrial fibrillation on the levels of NT-proBNP versus GDF-15 in patients with heart failure
por: Santema, Bernadet T., et al.
Publicado: (2020)

A network analysis to identify pathophysiological pathways distinguishing ischaemic from non‐ischaemic heart failure
por: Sama, Iziah E., et al.
Publicado: (2020)

First-in-Man Demonstration of Direct Endothelin-Mediated Natriuresis and Diuresis
por: Hunter, Robert W., et al.
Publicado: (2017)

Effects of urodilatin on natriuresis in cirrhosis patients with sodium retention
por: Carstens, Jan, et al.
Publicado: (2007)

Dissociation of natriuresis and diuresis by oxytocin molecular forms in rats
por: Jankowski, Marek, et al.
Publicado: (2019)

Atrial natriuretic factor: is it responsible for hyponatremia and natriuresis in neurosurgery?
por: Gasparotto, Ana Paula Devite Cardoso, et al.
Publicado: (2016)

Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin–angiotensin–aldosterone inhibitors
por: Sama, Iziah E, et al.
Publicado: (2020)

Clinical determinants and prognostic implications of renin and aldosterone in patients with symptomatic heart failure
por: Kobayashi, Masatake, et al.
Publicado: (2020)

Characteristics and clinical outcomes of patients with acute heart failure with a supranormal left ventricular ejection fraction
por: van Essen, Bart J., et al.
Publicado: (2022)

Low circulating microRNA levels in heart failure patients are associated with atherosclerotic disease and cardiovascular-related rehospitalizations
por: Vegter, Eline L., et al.
Publicado: (2017)

Sustained resveratrol infusion increases natriuresis independent of renal vasodilation
por: Gordish, Kevin L., et al.
Publicado: (2014)

Pathophysiological pathways in patients with heart failure and atrial fibrillation( )
por: Santema, Bernadet T, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5nc1no1kh2fo4slpg024knnkfr